Floatz logo

IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER

Lymphomas: Non-Hodgkin Peripheral T-Cell

Stanford Universitymonoclonal_antibodyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

36 Active assets in the Lymphomas: Non-Hodgkin Peripheral T-Cell cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Alliance for Clinical Trials in Oncology
Phase 4BB
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
DEXAMETHASONE
Zhengzhou University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 2BB
(+)-VINCRISTINE
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G, ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IMMU-HLL2 .KAPPA.-CHAIN, DIMER is also rated in:

non-Hodgkin lymphomaDormant
BB
Indicative ·
64 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
58 / 100
View asset →
acute lymphoblastic leukemiaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →